ireland, a winning proposial for research, development and innovation-ireland

8/14/2019 Ireland, a winning proposial for Research, Development and Innovation-ireland

1/22

A WINNING PROPOSITION FOR

RESEARCH, DEVELOPMENT &

INNOVATION


2/22

CONTENTS01_ IRELAND - A PRIME LOCATION

FOR RD&I

02_ HOW IRELAND DELIVERS ON

ITS RD&I PROMISES

03_IRELANDS RD&I FRAMEWORK04_THE IRISH ADVANTAGE

P02

P04

P08P18


3/22

The Irish Government is ocused on driving economic growth by encouraging

urther RD&I activities. Its strategic objectives are backed with positive action through

an unprecedented investment o 8.2 billion under the Governments strategy or

Science Technology and Innovation. This unding is already building a world class

research system. The science strategy is also ensuring that all elements are working

in unison or the benet o industry. It is the Smart Economy made real.

Todays Ireland oers a strong, growing RD&I environment - complemented by a

robust Intellectual Property (IP) regime; a young skilled and well-educated workorce

with strong technological and business skills; and a low corporation tax.

The Drivers o Global RD&I

Access to the best talent, research and technology

Convergence between previously separate industries

The rate o continuous innovation required to keep pace with new business models

Research hotspots and networks that support and encourage RD&I

01_IRELAND A PRIME

LOCATION FOR RD&I

In every area o the contemporary business world,

progressive companies ace an ever-increasing demand to

innovate. This drive or advancement is one o the main

catalysts or the internationalisation o Research, Development

and Innovation (RD&I).

Ireland is now considered one o the leading RD&I locations in the

world. Ireland has the capacity to meet the needs o RD&I investors

and oers the ideal commercial, political and social environment

in which to carry out successul and protable RD&I activities.

02


4/22

IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION

03

+_IRELAND: yOu ARE IN

GOOD COMPANy

What Ireland Oers

A pro-business environment with a 12.5% corporate tax rate

A long-established track record o working with multinational

corporations (MNCs)

Strong Intellectual Property protection

Well-established collaboration between a world-class academic

sector and industry

A highly-skilled workorce with strong managerial andcommunication abilities

Support and access to Government unding and RD&I networks

through IDA Ireland and Science Foundation Ireland

Excellent business inrastructure and Inormation and

Communications Technology (ICT)


5/22

Collaborative Research Environment

A unique eature o the Irish business environment is the

productive collaboration between industry, academia and

government agencies. All stakeholders work together,

building a national team to consolidate Irelands position

as a knowledge-based economy and as a primary locationor RD&I.

04

02_HOW IRELAND DELIVERS

ON ITS RD&I PROMISES

Irelands RD&I Landscape

ResearchCentres

GovernmentAgencies

Education/Third Level

GovernmentDepartments

Regulation

Industry


6/22


05

IDA Ireland plays a leading role in RD&I development by providing

unding support to suitable projects, and by identiying other

supports available rom partner organisations such as Enterprise

Ireland, Science Foundation Ireland, and Sustainable Energy Ireland.

In addition to RD&I unding, IDA Ireland has a number o direct

support mechanisms, including employment and training grants.

Through its property portolio, IDA also has a suite o property

oerings or companies.

IDA Ireland works closely with companies to ensure they have the

acilities, resources and support they need to establish and expand

their RD&I operations. IDA helps ensure these progressive companies

continue to fourish here as key drivers o Irelands uture economic

success.

A Comprehensive Range o RD&I Programmes

IDA Irelands RD&I Programme, and Feasibility and

Training Support

Enterprise Irelands Innovation Partnerships Initiative

IDA Ireland/Enterprise Ireland Competence Centres

SFI Centres or Science, Engineering and Technology (CSET)

Programme EU 7th Framework Programme or Research and Technological

Development (FP7)

+_WORKING WITH yOu AND OTHERS


7/22

Centres for Science, Engineering and Technology (CSETs)

These centres are unded by Science Foundation Ireland and are ormed by clusters

o internationally competitive researchers rom the third-level sector and industry.

Their purpose is to exploit and develop opportunities in science engineering and

technology; in particular research that underpins developments in Biotechnology

ICT and Renewable Energy sectors.

A notable example is the Centre or Research on Adaptive Nanostructures &

Nanodevices (CRANN), located at Trinity College Dublin. The aim o CRANN is to

deliver world class research and innovation in nanoscience and nanotechnology

which will address key industry challenges. CRANN is a critical component o an

integrated national strategy to transition Ireland to a knowledge economy.

CRANNs industrial partners include Intel and H.P, with both companies having

researchers-in-residence in the CRANN acility.

RD&I Competence Centres

These are collaborative entities established and led by industry. They are resourced

by highly-qualifed researchers associated with research institutions who undertakemarket ocused strategic RD&I or the beneft o industry.

An RD&I Competence Centre is ormed when a group o companies come together

to defne their common research interest. The group then submits an expression

o interest to IDA Ireland or Enterprise Ireland outlining areas o common interest,

market presence and the strategic impact o a competence centre on their business

model. Expressions o interest that show highest potential impact will be selected to

progress or government unding. Participating companies must be open to working

with likeminded companies and prepared to collaborate with research perormers.Multinational companies that have participated to date include Medtronic, Intel,

Xilinx, Seagate, Analog Devices, DePuy and Bombardier Aerospace.

The National Institute for Biotechnology Research and Training (NIBRT)

NIBRT is an IDA-supported collaboration between our leading Irish academic

institutions. Its purpose is to deliver state-o-the-art training/learning acilities and

research solutions or the advancement o the BioPharma sector in Ireland.

+_ExamplEs of RD&I pRogRammEs

06


8/22

+_OTHER ELEMENTS INFLuENCING

RD&I IN IRELAND

Irish enterprise policy is ocused on creating

a smart economy or Ireland; an economy which

has at its core an exemplary research, innovation

and commercialisation ecosystem.

Key Elements o IDA Irelands RD&I Strategy

Leveraging recent investment by the Irish Government in RD&I

to support, develop and encourage multinational corporations

(MNCs) to undertake RD&I in Ireland

Fostering an environment o collaboration between government,

academia and MNCs

Ensuring RD&I policies are business riendly and attractiveto MNCs

Promoting Ireland as a location or carrying out world-class

RD&I

07IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION


9/22

08

Ireland oers a world-class research development

and innovation (RD&I) model that delivers success or global

companies like AON, Intel, PayPal and Boston Scientic.

The ollowing sections explain how Ireland recognises the

optimum conditions needed or these companies to fourish

in the global RD&I environment.

03_IRELANDs RD&I FRAMEWORK

Key Elements of Irelands RD&I Success

A strong commitment and ocus by the Irish Government to RD&I

Irish legislation provides MNCs with incentives to generate qualiying

patents up to 5 million annual qualiying income can be exempt

rom Irish tax

R&D tax credit designed to encourage companies to undertake

new or additional R&D activity in Ireland. The tax credit covers wages,plant/machinery, buildings and related overheads o establishing an

RD&I activity in Ireland

A tax rate o 12.5% applies to all corporate trading prots

Clusters o global leaders in key high tech industries including

Pharmaceuticals, Medical Devices, Biotechnology, ICT and

Financial Services


10/22


09

THE STANDALONEMODELIn this model, a company establishes a

dedicated centre to support either corporateresearch or an innovation agenda through

a standalone acility in Ireland.

THE COLLAbORATIVEMODELThe Collaborative Model describes an

RD&I investment that is co-dependent on a

substantial collaborative engagement with

an Irish or international academic institution

and/or with a MNC or indigenous Irish

company. You could call it a meeting o

minds and cross-discipline brainpower.

DEVELOPMENT &

MANuFACTuRING/SERVICE DELIVERyMODELThis reers to RD&I done at a

manuacturing or service delivery site

that improves the manuacturing or

service delivery process to achieve

greater productivity, eiciency and

quality o the operation or service.

THE DEVELOPMENT &

COMMERCIALISATIONMODELThe Development & Commercialisation

Model relates to instances o RD&I investments

where the outputs will be developed and

produced in Ireland or export markets.

+_FOuR MODELS FOR RD&I


11/22

Standalone Success in RD&I

Ireland has proven itsel a successul location or companies

wishing to establish standalone RD&I. As part o their

overall RD&I strategy and complimented by the skillsetso Irish researchers, a wide range o global companies have

successully managed to capture rst-mover advantage in

innovation, product development and design by setting up

RD&I Centres o Excellence in Ireland.

10

*THE STANDALONE

MODEL


12/22

CASE STuDIES


11

CASE STuDIES

CiscoA worldwide leader in networking and collaboration products and services, Cisco

invested in a dedicated site or 250 research and development sta in Galway City.

From the outset, the Galway initiative has established a global leadership mandate in

Ciscos Unied Communications and Collaboration (UCC) portolio. Research conducted

here is at the very heart o Ciscos strategy in empowering The Human Network.

The project has established strong research partnerships and linkages with the

Science Foundation Ireland (SFI) unded CSET at the Digital Enterprise Research

Institute (DERI) in University College Galway, and with the Telecommunications

Sotware & Systems Group (TSSG) in Waterord Institute o Technology (WIT).

The Galway acility is also host to a European UCC customer brieng centre enabledby Ciscos TelePresence video technology.

AONIn nancial services, product and process innovation is now a core activity in driving

the strategic importance o the Irish operations. AON - providers o risk management

services, insurance and reinsurance brokerage - created an industry-rst when

choosing Dublin as the location or a Global Centre o Excellence. The Centre will

systematically aggregate inormation rom around the world using sophisticated

mathematical and analytical techniques, which Aon will translate into real-time

insights and innovative insurance products and risk solutions tailored to clients needs.This Centre o Excellence provides advanced research and development technology,

enabling the rm to drive product, process and business model innovation across

several disciplines.

HelsinnHelsinn, a privately owned pharmaceutical company, has established a Centre o

Excellence in Research and Development or Oral Solid Dosage (OSD) at its Dublin

acility, Helsinn Birex Pharmaceuticals. Helsinns core business is the in-licensing o

late stage pharmaceutical compounds in therapeutic niche areas or development

and subsequent commercial manuacture and distribution. The company is primarily

active in oncology supportive care, anti-infammatory and gastrointestinal treatments.

The investment is part o Helsinns strategic decision to strengthen its in-house

development capabilities. The Helsinn investment will establish the Irish operation

as the centre o knowledge and learning or OSD products in the Helsinn Group, and

the launch site or new products within its portolio. This investment puts the Irish

operation at the core o Helsinns R&D activities.


13/22

Irelands Collaborative Business Culture

Collaboration between industry and third level institutions

has become an important component o the Irish RD&I

landscape. More and more companies are orming industry/academic alliances to share costs and avail o the unique

skills available in research-perorming academic institutions

in Ireland.

12

*THE COLLAbORATIVE

MODEL


14/22


13

CASE STuDIESCASE STuDIES

GlaxoSmithKlineGlaxoSmithKline (GSK) is one o the largest pharmaceutical companies in the world.

In its Irish RD&I operations, GSK is developing a ground-breaking research project

into gastrointestinal diseases, in collaboration with the Alimentary Pharmabiotic

Centre (APC) in University College Cork. This project is jointly supported by IDA Ireland

and Science Foundation Ireland (SFI). The company is also investing in a unique

collaboration with the Trinity College Institute o Neuroscience (TCIN) and the National

University o Ireland (NUI) Galway on a major Research & Development programme or

the discovery o new therapies to treat Alzheimers Disease.

IntelThe Irish campus is home to Intels IT Innovation Centre which is involved in ar-reaching research & development o applications including peer-to-peer networks,

digital health, mobility solutions, education deployment technologies (including

wireless & satellite) and e-learning architectures and platorms. The Irish operations

have responsibility or the direct management and governance o Intels innovation

labs across Europe. Intel also has an operation in Shannon, Co Clare designing

advanced microprocessors or use in embedded computing communications and

storage markets. Intel recently announced the expansion o this operation involving

industrial research in silicon design and validation and the development o a content

processor module. Intel is collaborating in this area with the Centre or Researchon Adaptive Nanostructures & Nanodevices (located at Trinity College Dublin),

the Tyndall National Institute in Cork and the National University o Ireland in

Maynooth.

Smith & NephewSmith & Nephew, the global medical technology company, and REMEDI, the

Regenerative Medicine Institute at NUI Galway, established a our year R&D

collaborative programme or the development o treatments or bone and joint

diseases. The Smith & Nephew Research Centre in York, United Kingdom, is working

in partnership with REMEDI to develop new therapies using adult bone marrow stem

cells to promote the re-growth o healthy cartilage and the repair o damaged joints.

REMEDI, recognised as Irelands primary centre or stem cell and gene therapy

research, was established as a Centre or Science, Engineering and Technology

(CSET ) in 2004 by Science Foundation Ireland. It has a core expertise in arthritis

research and a particular emphasis on the translation o its research ndings to

the delivery o new therapies in orthopaedics, cardiovascular and neural diseases.


15/22

The Development and Manuacturing/Service Delivery

Model reers to RD&I carried out at a manuacturing or

service delivery site that improves the manuacturing or

service delivery process to achieve greater productivity,eciency and quality o the operation.

14

*DEVELOPMENT &

MANuFACTuRING/SERVICE

DELIVERy MODEL


16/22

Stryker InstrumentsStryker Instruments, part o the Stryker Corporation, is known or a wide range

o innovative operating room products - rom surgical power tools to advanced

systems or waste management, irrigation, personal protection and pain management.

Established in 1998, Strykers Cork plant has successully developed a state-o-the-art

research and development and manuacturing acility or minimally invasive surgical

instruments. These products are used or cutting, drilling, burring and shaping o

bone and sot tissue during orthopaedic, spine, ear, nose and throat plastic surgery.

The R&D team in Cork is involved in both product and process development with

sole responsibility or the development, pilot manuacturing, regulatory approval

and commercial manuacture o disposable bone and sot tissue cutting instruments.

MerckMerck established its rst Irish operation in Co. Tipperary in 1976. The construction

o a new 200,000 sq t acility in Ireland when complete, will enable all the unit

processes to manuacture nal stage (Phase III) clinical trial solid dosage (tablets &

capsules) or global clinical trials. The acility will be used to manuacture, market

and launch quantities o newly approved drugs prior to their manuacture in long term

supply sites. Signicant parts o this operation will have a large R&D element involved

in new process development including Process Analytical Technology and in-process

measurement systems, tablet & capsule ormulation development, and thedevelopment o new analytical methods or each new medicine.

PaypalPaypal, an eBay company, set up their European Operations Centre (EOC) in Dublin

in 2003, serving markets in Italy, France, Germany, Spain, UK, Netherlands and Poland.

Paypal Ireland now employs some 900 ulltime sta across it portolio o activities

such as European Customer Services, Risk & Fraud Management and Merchant

Solutions. The company recently initiated a Customer Centre o Excellence which

will see the EOC evolve into an operation with responsibility or developing Customer

Service and Operational Excellence within the PayPal Group. The Centre o Excellence

will be involved in re-engineering the end-to-end customer experience working

across European operations and with the companys European Business Units to

dene and implement innovative solutions in product, process, policy and technology;

a signicant upward move in relation to value added activities. PayPals Centre o

Excellence will be working with the Innovation Value Institute in the National

University o Ireland at Maynooth.



15


17/22

16

Commercialisation is the successul implementation o a novel

idea into something o value to the marketplace. The successul

commercialisation o new products or services in Ireland can

lead to increased revenue, market share, and protability.Ireland has a strong track record o companies developing and

delivering new products and services to the market across a

wide sectoral range.

*THE DEVELOPMENT AND

COMMERCIALISATION

MODEL


18/22

AnalogThe ocus o Analogs Irish operation is to produce quality precision products through

precision manuacturing, while exploiting cost-eciencies. Innovation is ostered

through teamwork, both within the Irish operation and through cross-national

research teams throughout Analog Devices globally. The company has recently

upgraded its waer manuacturing acility in Limerick moving rom a 6 ab to an

8 ab. The Limerick based R&D team o over 400 engineers are involved in IC layout,

Analog design (custom transistor level design), Digital/ASIC design, system design,

product/test engineering and semiconductor process technology. Access to R&D and

highly skilled manuacturing and technological experts allows the Ireland operation

develop an average o 80 new products each year. The Irish R&D team has soleresponsibility within Analog or the global design, manuacture and supply o value

added high voltage mixed signal CMOS products.

Boston ScientifcBoston Scientic specialises in manuacturing medical devices or use in minimally

invasive surgical procedures. The company set up its rst operation in Ireland in

1994, in Galway. The Galway acility is the companys largest operation in Ireland,

manuacturing cardiology related products stents, catheters and guidewires.

This operation also has one o the largest R&D teams in Ireland. Boston Scientic

has recently announced an RD&I investment at its Cork acility refecting theenhanced capability o this acility or the development and commercialisation o

next generation products to treat neurovascular diseases o the brain, including coils,

intracranial stent delivery systems and access devices. Boston Scientic Corporation

currently employs 5,000 people in Ireland.

MedtronicMedtronic has been present in Ireland since 1999. Medtronics Galway site is a Centre

o Excellence or the development and manuacture o key medical technologies in

the treatment and management o cardiovascular and cardiac rhythm diseases,

employing over 2000 people in Ireland working at state-o-the-art acilities in Galway.

This gure includes over 90 Research & Development personnel working on a number

o high value projects such as the development o next generation cardiovascular

products and Cardiac Rhythm Disease Management delivery systems. A large

proportion o the products manuactured at Medtronics Galway site result rom R&D

carried out at the acility. The company also maintains R&D links with many third

level institutions throughout Ireland as the countrys academic climate gives

it access to highly-trained medical technology research and development experts.



17


19/22

18

Ireland is a proven location or RD&I with a successul

track record across multiple industry sectors, based on the

unique combination o benets on oer to global business:

A stable political environment and respected regulatory regime A pro-business environment with a 12.5% corporate tax rate, tax credits

or RD&I activities and an extensive double tax treaty network with

51 countries

A high-skills, knowledge-based economy delivering quality, highly

productive employees with excellent technical, managerial and

multilingual customer service skills

A reputation or fexibility, responsiveness and innovation

Forty years experience working with MNCs to establish andexpand operations across a wide range o sectors

Clusters o global leaders in key high tech industries including

pharmaceuticals, medical devices and ICT

Experienced and innovative leaders ocused on proactively

identiying and solving business challenges

Strong Government support or RD&I ocused on highly

productive alliances between industry and academia

Excellent legal expertise or the commercialisation andprotection o intellectual property rights

04_THE IRISH ADVANTAGE


20/22

19IRELAND A WINNING PROPOSITION FOR RESEARCH, DEVELOPMENT AND INNOVATION

+_CONTACT IDA IRELAND

IDA Ireland oers inormation, advice and ongoing support

to companies setting up or expanding RD&I operations in Ireland.

IDA Ireland is Irelands inward investment promotion agency.

The agency works with companies to secure new investment

and collaborates with existing oreign investors in Ireland to

help expand and develop their businesses. To learn more log

on to www.idaireland.comor contact any IDA oce.

HeadquartersIDA Ireland, Wilton Place,Dublin 2, Ireland.Tel: +353 1 603 4000Fax: +353 1 603 4040e-mail: [email protected]:www.idaireland.com


21/22

20

+_IDA GLObAL OFFICE NETWORK

IRELAND

India501, 5th Floor,Blue Wave Building,B/h Kuber Complex,O Oshiwara Link Road,

Andheri (West),Mumbai-400 053Tel: +91-22-42178900Fax:+91-22-42178999

JapanIreland House 2F2-10-7 KojimachiChiyoda-KuTokyo 102-0083Tel: +81 3 3262 7621Fax: +813 3261 4239

Korea13th Floor Leema B/D

146-1 Susong-dong, Jongro-kuSeoul 110-755Tel: +82 2 755 4767/8Fax: +82 2 757 3969

Taiwan7FL-12, No.41Nanking W. RoadTaipei 103TaiwanTel: +886 2 2552 6101Fax: +8862 2550 7220

AthloneAthlone Business &Technology ParkGarrycastle, Dublin Rd.

AthloneWestmeathTel: +353 (0) 90 64 71500Fax: +353 (0) 90 64 71550

CavanIDA Business ParkDublin RoadCavanTel: +353 (0) 49 436 8820Fax: +353 (0) 49 433 2047

CorkIndustry HouseRossa Avenue

BishopstownCorkTel: +353 (0) 21 480 0210Fax: +353 (0) 21 480 0202

DonegalPortland HousePort Road, LetterkennyDonegalTel: +353 (0) 74 916 9810Fax: +353 (0) 74 916 9801

DundalkFinnabair Business ParkDundalkLouthTel: +353 (0) 42 935 4410Fax: +353 (0) 42 935 4411

GalwayMervue Business ParkGalwayTel: +353 (0) 91 735 910Fax: +353 (0) 91 735 911

LimerickRoselawn HouseNational Technology ParkLimerickTel: +353 (0) 61 200 513Fax: +353 (0) 61 200 399

SligoFinisklin Business ParkSligoTel: +353 (0) 71 915 9710Fax: +353 (0) 71 915 9711

Waterord

Waterord Technology ParkCork RoadWaterordTel: +353 (0) 51 333 055Fax: +353 (0) 51 333 054

FranceMaison dIrlande33 rue de Miromesnil75008 ParisTel: +33 (0) 1 43 12 91 80Fax: +33 (0) 1 47 42 84 76

GermanyFBC Frankurter Bro CenterMainzer Landstr. 4660325 Frankurt am MainTel: +49 (0) 69 706099-0Fax: +49 (0) 69 706099-70

AtlantaMonarch Plaza,Suite 3503414 Peachtree Road,N.E., Atlanta,GA 30326Tel: +1 404 816 7096Fax:+1 404 846 0728

Boston31 Saint James Avenue,7th Floor, Boston,MA 02116.Tel: +1 617 357 4190Fax:+1 617 357 4198

Caliornia3 Park Plaza,Suite 430,Irvine, CA 92614.Tel: +1 949 748 3547Fax:+1 949 748 3586

800 W. El Camino RealSuite 450,Mountain View, CA 94040Tel: +1 650 967 9903Fax:+1 650 967 9904

RussiaEmbassy o IrelandGrokholski Pereulok 5Moscow 129010Tel: +7 495 937 5911Fax: +7 495 680 0623

United KingdomShatesbury House151 Shatesbury AvenueLondon WC2H 8ALTel: +44 (0) 20 7379 9728Fax: +44 (0) 20 7395 7599

BrazilAv. das Naes Unidas,12551 - 17 andar04578-903 S. Paulo - SPBrazilTel: +55 11 3443 7080Fax:+55 11 4992 0406

AustraliaIreland HouseSuite 2601, Level 261 Market StreetSydney NSW 2000Tel: +61 (0)2 9273 8524Fax:+61(0)2 9273 8527

ChinaSuite 655Shanghai Centre1376 Nanjing Road WestShanghai 200040Tel: +86 21 6279 8500Fax:+86 21 6279 8505

EUROPE

USA

SOUTH AMERICA

ASIA-PACIFIC

Chicago77 West Wacker DriveSuite 4070Chicago, IL 60601-1629Tel: +1 312 236 0222Fax: +1 312 236 3407

New York345 Park Avenue, 17th FloorNew York, NY 10154-0004Tel: +1 212 750 4300Fax: +1 212 750 7357


22/22

WWW.IDAIRELAND.COM

DESIG

NBYCREATIVEINC

ireland, a winning proposial for research, development and innovation-ireland

Documents